| Mark C Morris, MD | |
|
4500 Memorial Drive, Belleville, IL 62223 | |
| (618) 257-4076 | |
| Not Available |
| Full Name | Mark C Morris |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 31 Years |
| Location | 4500 Memorial Drive, Belleville, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063512705 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital | Belleville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Anesthesia Providers Sc | 9830480581 | 139 |
News Archive
U.S. Supreme Court Justice Antonin Scalia on Friday in a speech at the University of Delaware said that Roe v. Wade, the 1973 Supreme Court ruling that effectively barred state abortion bans, is not a precedent he is willing to accept, the Wilmington News Journal reports.
Today's headlines include reports about the announcement by the Department of Health and Human Services that people who get their health insurance through high-risk insurance pools will have an extra two months before this program ends.
Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis, according to a study presented by the University of Pittsburgh Medical Center (UPMC) at the American Society of Clinical Oncology Prostate Cancer Symposium, Feb. 24 to 26 at the San Francisco Marriott.
Tragara Pharmaceuticals, Inc. announced today that apricoxib in combination with erlotinib demonstrated significant and consistent clinical benefit over erlotinib alone in a clinically relevant subset of biomarker-selected patients with non-small cell lung cancer (NSCLC) who had previously failed a platinum-containing regimen for advanced disease.
› Verified 6 days ago
| Entity Name | Anesthesia Associates Of Belleville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932141561 PECOS PAC ID: 5890690812 Enrollment ID: O20031203000567 |
News Archive
U.S. Supreme Court Justice Antonin Scalia on Friday in a speech at the University of Delaware said that Roe v. Wade, the 1973 Supreme Court ruling that effectively barred state abortion bans, is not a precedent he is willing to accept, the Wilmington News Journal reports.
Today's headlines include reports about the announcement by the Department of Health and Human Services that people who get their health insurance through high-risk insurance pools will have an extra two months before this program ends.
Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis, according to a study presented by the University of Pittsburgh Medical Center (UPMC) at the American Society of Clinical Oncology Prostate Cancer Symposium, Feb. 24 to 26 at the San Francisco Marriott.
Tragara Pharmaceuticals, Inc. announced today that apricoxib in combination with erlotinib demonstrated significant and consistent clinical benefit over erlotinib alone in a clinically relevant subset of biomarker-selected patients with non-small cell lung cancer (NSCLC) who had previously failed a platinum-containing regimen for advanced disease.
› Verified 6 days ago
| Entity Name | Midwest Anesthesia Providers Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295189082 PECOS PAC ID: 9830480581 Enrollment ID: O20160628000182 |
News Archive
U.S. Supreme Court Justice Antonin Scalia on Friday in a speech at the University of Delaware said that Roe v. Wade, the 1973 Supreme Court ruling that effectively barred state abortion bans, is not a precedent he is willing to accept, the Wilmington News Journal reports.
Today's headlines include reports about the announcement by the Department of Health and Human Services that people who get their health insurance through high-risk insurance pools will have an extra two months before this program ends.
Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis, according to a study presented by the University of Pittsburgh Medical Center (UPMC) at the American Society of Clinical Oncology Prostate Cancer Symposium, Feb. 24 to 26 at the San Francisco Marriott.
Tragara Pharmaceuticals, Inc. announced today that apricoxib in combination with erlotinib demonstrated significant and consistent clinical benefit over erlotinib alone in a clinically relevant subset of biomarker-selected patients with non-small cell lung cancer (NSCLC) who had previously failed a platinum-containing regimen for advanced disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark C Morris, MD 940 West Port Plaza, Ste 270, St Louis, MO 63146 Ph: (314) 453-0600 | Mark C Morris, MD 4500 Memorial Drive, Belleville, IL 62223 Ph: (618) 257-4076 |
News Archive
U.S. Supreme Court Justice Antonin Scalia on Friday in a speech at the University of Delaware said that Roe v. Wade, the 1973 Supreme Court ruling that effectively barred state abortion bans, is not a precedent he is willing to accept, the Wilmington News Journal reports.
Today's headlines include reports about the announcement by the Department of Health and Human Services that people who get their health insurance through high-risk insurance pools will have an extra two months before this program ends.
Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis, according to a study presented by the University of Pittsburgh Medical Center (UPMC) at the American Society of Clinical Oncology Prostate Cancer Symposium, Feb. 24 to 26 at the San Francisco Marriott.
Tragara Pharmaceuticals, Inc. announced today that apricoxib in combination with erlotinib demonstrated significant and consistent clinical benefit over erlotinib alone in a clinically relevant subset of biomarker-selected patients with non-small cell lung cancer (NSCLC) who had previously failed a platinum-containing regimen for advanced disease.
› Verified 6 days ago
Dr. Paul D Sander, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4500 Memorial Dr, Anesthesia Dept, Belleville, IL 62226 Phone: 618-257-4076 | |
Robert Hellman, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 311 W Lincoln St, Suite 101, Belleville, IL 62220 Phone: 618-222-3200 Fax: 618-222-3203 | |
Kathleen H Slocomb, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Drive, Belleville, IL 62223 Phone: 618-257-4076 | |
Dr. Abdurrahim M Abdulhadi, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4500 Mem. Drive, The Memorial Hospital, Belleville, IL 62223 Phone: 618-233-7750 Fax: 618-257-6946 | |
Waqqas H Khan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 211 S 3rd St, Belleville, IL 62220 Phone: 618-234-2120 Fax: 618-641-5810 | |
Randolph M Freeman, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 4500 Memorial Drive, Belleville, IL 62223 Phone: 618-257-4076 |